Peter Schirmacher
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Biochemistry top 2%
- Oncology
- Co-authors
- Beate K. StraubHans HeidRalf ZimbelmannEsther HerpelRoland PenzelWolf MuellerM. RotterJuergen Brieger
- Topics
- Cancer, Hypoxia, and Metabolism (4 papers)Cancer, Lipids, and Metabolism (4 papers)Cancer Genomics and Diagnostics (4 papers)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Peter Schirmacher
21 papers receiving 834 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 390
- Cancer Research 320
- Pulmonary and Respiratory Medicine 241
- Biochemistry 194
- Oncology 188
Countries citing papers authored by Peter Schirmacher
This map shows the geographic impact of Peter Schirmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schirmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schirmacher more than expected).
Fields of papers citing papers by Peter Schirmacher
This network shows the impact of papers produced by Peter Schirmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schirmacher. The network helps show where Peter Schirmacher may publish in the future.
Co-authorship network of co-authors of Peter Schirmacher
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Schirmacher. A scholar is included among the top collaborators of Peter Schirmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Schirmacher. Peter Schirmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 138 | |
| 5 | 42 | |
| 6 | 36 | |
| 7 | 198 | |
| 8 | Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. | 22 |
| 9 | [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer]. | 3 |
| 10 | 1 | |
| 11 | [The anti-diabetic drug troglitazone sensitizes colon cancer cells to TRAIL-induced apoptosis by down-regulating FLIP]. | 1 |
| 12 | 33 | |
| 13 | 21 | |
| 14 | 8 | |
| 15 | [Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?]. | 1 |
| 16 | VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. | 181 |
| 17 | 49 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 13 |
About Peter Schirmacher
Peter Schirmacher is a scholar working on Cancer Research, Biochemistry and Oncology, having authored 21 papers that have together received 849 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Biochemistry (194 citations), Cancer Research (320 citations) and Pulmonary and Respiratory Medicine (241 citations). Peter Schirmacher has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Beate K. Straub, Hans Heid, Ralf Zimbelmann, Esther Herpel, Roland Penzel, Wolf Mueller, M. Rotter, Juergen Brieger, Gregor Weirich and Damjan Glavač. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.